A meta-analysis of controlled trials of recombinant human activated protein C therapy in patients with sepsis
<p>Abstract</p> <p>Background</p> <p>Meta-analysis of two randomised controlled trials in severe sepsis performed with recombinant human activated protein C may provide further insight as to the therapeutic utility of targeting the clotting cascade in this syndrome.<...
Main Authors: | Wiedermann Christian J, Kaneider Nicole C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-10-01
|
Series: | BMC Emergency Medicine |
Online Access: | http://www.biomedcentral.com/1471-227X/5/7 |
Similar Items
-
Role of human recombinant activated protein C and low dose corticosteroid therapy in sepsis
by: Aparna Shukla, et al.
Published: (2010-01-01) -
Updates on role of human recombinant activated protein C in patients with sepsis and severe sepsis: Changed scenario after PROWESS SHOCK trial
by: Aparna Shukla
Published: (2012-01-01) -
Use of Recombinant Activated Protein C in Therapy for Sepsis in Children after Cardiosurgical Interventions
by: Ye. Yu. Ochakovskaya, et al.
Published: (2008-04-01) -
What is the role of recombinant activated protein C in the management of sepsis?
by: Juan Alvarado, et al.
Published: (2016-12-01) -
Guidance on patient Identification and Administration of Recombinant Human Activated protein C for the Treatment of Severe Sepsis
by: Gary Garber, et al.
Published: (2002-01-01)